Dr. Omar Qazi, MD

Dr. Qazi practices at Arnold Palmer Hospital for Children in Orlando, Florida.

Dr. Qazi's NPI, 1053653865, was assigned on March 19, 2013. Dr. Qazi graduated from USF Health Morsani College of Medicine in 2013. Dr. Qazi holds Florida license ME126642.

Dr. Qazi's primary practice is Arnold Palmer Hospital for Children, at 92 W Miller St, Orlando, FL 32806 in Orange County. The practice phone is (407) 650-5028.

Dr. Qazi's primary practice is Arnold Palmer Hospital for Children in Orlando, Florida. Dr. Qazi is also affiliated with Orlando Regional Medical Center. The medical group on file is Orlando Health Medical Group. Dmand AI also links Dr. Qazi to 1 more hospital, 4 home health agencies, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Qazi practices, 8 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Qazi's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Qazi is board certified in internal medicine by the American Board of Internal Medicine. Dr. Qazi is licensed in Florida.

Dmand AI lists anemia, gastrointestinal inflammation, seizures and sepsis among the conditions Dr. Qazi treats.

CMS data shows 24 Medicare services from Dr. Qazi across 1 procedure code in 2024, for 70 Medicare patients. Medicare paid $3,817 for them. Every service was in an office.

CMS counts 70 Medicare patients who saw Dr. Qazi in 2024. The largest group is 65 to 74, with 24 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Qazi's median patient age at 74, with 50% women.

In 2024, Dr. Qazi wrote 191 Medicare Part D claims for 67 patients. 79% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $53 in total drug cost. In 2021, CMS named 46 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Qazi for performance year 2024, reported as part of a group. Dr. Qazi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Qazi as offering telehealth.

Dmand AI links 16 papers to Dr. Qazi, published from 2006 to 2024. 2009 was the busiest year, with 2. The most frequent topics are Tetanus Toxin, Peptide Fragments and Antibodies, Bacterial. Dr. Qazi has published most often in Am J Case Rep. Dr. Qazi's most frequent co-authors are Mohammed Al Salihi, MD, Stephen Carlan, MD and Murali Krishna Iyyani, MD.

CMS Open Payments shows 9 general payments to Dr. Qazi from 8 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Phathom Pharmaceuticals, Inc. paid the most, $120.

Dr. Qazi graduated from USF Health Morsani College of Medicine in 2013.

Dr. Qazi is in network with 9 carriers, including Aetna, Excellus BlueCross BlueShield and Cigna. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.